vTv Therapeutics Files Registration Statement for Proposed Initial Public Offering

HIGH POINT, N.C.–(BUSINESS WIRE)–vTv Therapeutics LLC (vTv), a clinical-stage biopharmaceutical company engaged in the discovery and development of orally administered small molecule drug candidates, today announced it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission relating to a proposed initial public offering of shares of its Class A common stock. Piper Jaffray & Co. and Stifel are acting as joint book running managers for the offering. C

Print Friendly, PDF & Email

Share This

Share this post with your friends!